Moderna said it will apply for US and European emergency authorisation of its Covid-19 vaccine on Monday based on full results from a late-stage study showing its vaccine was 94.1% effective with no serious safety concerns.

It also reported a 100% success rate in preventing severe cases.…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.